← Back to Patent Explorer
US4177271A Expired / Lapsed US ⏱️ 0.0 years remaining

Hydroxy- and oxo-substituted α-benzylidenylcycloalkanes

Assignee: NOVAPHARME SARL A CORP OF FRANCE
•
Filing: 1978-07-25
•
Granted: 1979-12-04
•
Expires: 1998-07-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Hydroxy- and oxo-substituted α-benzylidenylcycloalkanes having the formula: ##STR1## Z 1 , Z 2 and Z 3 each denotes a methoxy group or Z 1 or Z 2 and Z 3 together denote a methylenedioxy group, and Z 3 is a hydrogen atom or chlorine atom, one of the symbols R 1 and R 2 denotes a hydrogen atom and the other denotes a hydroxyl group or, together the two denote an oxygen atom; R 3 denotes a hydrogen atom or a methyl group; R 4 denotes a hydrogen atom, a methyl group or an aminomethyl group, the amino group being a dimethylamino, diethylamino, morpholino, 4-methyl-piperazino or piperidino radical; or R 3 and R 4 together denote a piperonylidene group; R 5 denotes a hydrogen atom or a methyl group, and A forms, with the carbon atoms to which it is attached, a cyclopentane, cyclohexane, indane, tetrahydronaphthalene, perhydronaphthalene or piperidine structure and the pharmaceutically acceptable addition salts of the compounds containing an amino group. The compounds have pharmacological activity on the central nervous system.

Inventors

  • 👤 Francois M. J. Vallet

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 22:37
CPC Classifications
C; C07; C07C; C07C49/00; C07C49/587; C07C49/753; A; A61; A61P; A61P25/00; A61P25/08; A61P25/20; A61P25/24; A61P25/26; C07C43/00; C07C43/02; C07C43/20; C07C43/23; C07D; C07D317/00; C07D317/08; C07D317/44; C07D317/46; C07D317/48; C07D317/50; C07D317/54; C07D317/58

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 1 words
2-piperonylidene-6-morpholinomethylcyclohexanol.
Claim 2
Dependent Claim 1 words
2-piperonylidene-6-morpholinomethylcyclohexanol.
Claim 3
Dependent Claim 1 words
2-piperonylidene-6-methylcyclohexanol.
Claim 4
Dependent Claim 1 words
2-piperonylidene-6-methylcyclohexanol.
Claim 5
Dependent Claim 25 words
A method for treating anxious or depressive syndromes in a patient which comprises administering to said patient a pharmaceutical compound of claim 1 or 2.
Claim 6
Dependent Claim 24 words
A pharmaceutical composition for treatinan axious or depressive syndrome which contains a compound of claim 1 or 2 and a pharmaceutically acceptable carrier therefor.

References Cited (Backward Citations)

CA561942A Cited
US3468881A Cited
FR2154536A1 Cited
FR2253503B2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-12-03 1983-06-04 1983-12-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-12-03 1987-06-04 1987-12-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-12-03 1991-06-04 1991-12-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag